ES2177644T3 - Procedimiento para la resolucion de etodolac utilizando derivados de glucamina. - Google Patents
Procedimiento para la resolucion de etodolac utilizando derivados de glucamina.Info
- Publication number
- ES2177644T3 ES2177644T3 ES95915264T ES95915264T ES2177644T3 ES 2177644 T3 ES2177644 T3 ES 2177644T3 ES 95915264 T ES95915264 T ES 95915264T ES 95915264 T ES95915264 T ES 95915264T ES 2177644 T3 ES2177644 T3 ES 2177644T3
- Authority
- ES
- Spain
- Prior art keywords
- etodolac
- pct
- resolution
- glucamine
- procedure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
- C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
- C07C215/10—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic with one amino group and at least two hydroxy groups bound to the carbon skeleton
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pain & Pain Management (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
SALES DE GLUCAMINA O N-(C 1-4 ALQUIL)GLUCAMINA (FORMULA 1) CON S-ETODOLACO, (FORMULA 2) PREFERIBLEMENTE LA SAL MEGLUMINA, SON PARTICULARMENTE APROPIADOS PARA PRODUCIR EFECTOS ANALGESICOS RAPIDOS. ESTAS SALES PUEDEN SER PREPARADAS MEDIANTE LA RESOLUCION DE EDOTOLACO RACEMICO USANDO COMO AGENTE DE RESOLUCION GLUCAMINA O UNA N-(C{SUB,1-4}ALQUIL)GLUCAMINA. ADEMAS, SALES DE S-ETODOLACO SOLUBLES EN AGUA EN GENERAL PUEDEN SER USADAS EN LA FABRICACION DE MEDICAMENTOS PARA EL USO EN ANALGESIA DE EFECTO RAPIDO Y EN EL TRATAMIENTO DE DOLORES CRONICOS, Y SON PARTICULARMENTE APROPIADOS PARA FORMULACIONES DE LIBERACION SOSTENIDA
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9407225A GB9407225D0 (en) | 1994-04-12 | 1994-04-12 | Chiroscience limited |
GBGB9501455.1A GB9501455D0 (en) | 1995-01-25 | 1995-01-25 | Analgesic agent and its use |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2177644T3 true ES2177644T3 (es) | 2002-12-16 |
Family
ID=26304688
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES95915264T Expired - Lifetime ES2177644T3 (es) | 1994-04-12 | 1995-04-11 | Procedimiento para la resolucion de etodolac utilizando derivados de glucamina. |
Country Status (9)
Country | Link |
---|---|
US (1) | US5811558A (es) |
EP (1) | EP0755398B1 (es) |
JP (1) | JPH09511516A (es) |
AT (1) | ATE221533T1 (es) |
AU (1) | AU2220695A (es) |
DE (1) | DE69527617T2 (es) |
ES (1) | ES2177644T3 (es) |
NO (1) | NO964346L (es) |
WO (1) | WO1995027713A1 (es) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5574183A (en) * | 1995-01-24 | 1996-11-12 | Albemarle Corporation | Preparation of optically active aliphatic carboxylic acids |
US6399093B1 (en) | 1999-05-19 | 2002-06-04 | Advanced Medical Instruments | Method and composition to treat musculoskeletal disorders |
US7361680B2 (en) * | 1999-07-23 | 2008-04-22 | The Regents Of The University Of California | Indole compounds useful for the treatment of cancer |
US7151100B1 (en) | 1999-07-23 | 2006-12-19 | The Regents Of The University Of California | Indole compounds useful for the treatment of cancer |
US7129262B2 (en) * | 1999-07-23 | 2006-10-31 | The Regents Of The University Of California | Indole compounds useful for the treatment of cancer |
US6545034B1 (en) | 1999-07-23 | 2003-04-08 | The Regents Of The University Of California | Use of etodolac for the treatment of chronic lymphocytic leukemia |
US7105560B1 (en) | 1999-07-23 | 2006-09-12 | The Regents Of The University Of California | Use of etodolac in the treatment of multiple myeloma |
GB0007239D0 (en) * | 2000-03-24 | 2000-05-17 | Nycomed Imaging As | Use |
US20040152672A1 (en) * | 2000-08-09 | 2004-08-05 | Carson Dennis A. | Indole compounds useful for the treatment of cancer |
US20030232794A1 (en) * | 2001-06-26 | 2003-12-18 | Cottam Howard B. | Use of STAT-6 inhibitors as therapeutic agents |
US7601846B2 (en) * | 2001-06-26 | 2009-10-13 | The Regents Of The University Of California | Compounds having activity as inhibitors of apoptosis |
GB0206505D0 (en) * | 2002-03-19 | 2002-05-01 | Euro Celtique Sa | Pharmaceutical combination |
WO2004026116A2 (en) * | 2002-09-19 | 2004-04-01 | The Regents Of The University Of California | Use of etodoclac to treat hyperplasia |
ITMI20031471A1 (it) | 2003-07-18 | 2005-01-19 | Chemi Spa | Processo per la racemizzazione dell'acido etodolico |
PT3056492T (pt) | 2004-10-08 | 2021-12-27 | Abbvie Inc | Sal de meglumina e formas cristalinas do mesmo de um fármaco (delafloxacina) |
CA2603783C (en) * | 2005-04-11 | 2014-11-18 | Abbott Laboratories | Pharmaceutical compositions having improved dissolution profiles for poorly soluble drugs |
ITMI20060894A1 (it) | 2006-05-05 | 2007-11-06 | Univ Catania | Ciclodestrine funzionalizzate con etodolac come agenti di rilascio sito specifico |
CA2653941C (en) | 2006-05-31 | 2013-01-08 | The Regents Of The University Of California | Substituted amino purine derivatives and uses thereof |
CN102850204B (zh) * | 2011-06-29 | 2015-08-19 | 徐州医学院 | 一种(s)-2-芳基丙酸类非甾体抗炎药的拆分方法 |
WO2013169218A1 (en) | 2012-05-08 | 2013-11-14 | Mahmut Bilgic | Pharmaceutical compositions of s-etodolac |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4501899A (en) * | 1983-08-16 | 1985-02-26 | American Home Products Corporation | Resolution of (+)-1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic acid using cholesteryl aniline |
US4520203A (en) * | 1983-08-16 | 1985-05-28 | American Home Products Corporation | Resolution of (±)-1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic acid using cinchonine |
US4544757A (en) * | 1984-02-16 | 1985-10-01 | American Home Products Corporation | Process for the resolution of pyrano[3,4-b]indole-1-acetic acids |
IT1207994B (it) * | 1986-01-03 | 1989-06-01 | Therapicon Srl | Sali idrosulubili di composti adattivita' antiinfiammatoria ed analgesica, loro preparazione ed utilizzo in composizioni farmaceutiche. |
GB8724763D0 (en) * | 1987-10-22 | 1987-11-25 | Aps Research Ltd | Sustained-release formulations |
EP0408496A3 (en) * | 1989-07-12 | 1992-07-01 | Ciba-Geigy Ag | Solid dosage form for pharmaceutical substances |
US5256293A (en) * | 1991-09-20 | 1993-10-26 | Research Corporation Technologies, Inc. | Separation of enantiomers of non-steroidal anti-inflammatory drugs and chiral selector therefor |
-
1995
- 1995-04-11 DE DE69527617T patent/DE69527617T2/de not_active Expired - Fee Related
- 1995-04-11 AU AU22206/95A patent/AU2220695A/en not_active Abandoned
- 1995-04-11 JP JP7526191A patent/JPH09511516A/ja not_active Ceased
- 1995-04-11 WO PCT/GB1995/000857 patent/WO1995027713A1/en active IP Right Grant
- 1995-04-11 US US08/727,503 patent/US5811558A/en not_active Expired - Fee Related
- 1995-04-11 EP EP95915264A patent/EP0755398B1/en not_active Expired - Lifetime
- 1995-04-11 AT AT95915264T patent/ATE221533T1/de not_active IP Right Cessation
- 1995-04-11 ES ES95915264T patent/ES2177644T3/es not_active Expired - Lifetime
-
1996
- 1996-10-11 NO NO964346A patent/NO964346L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP0755398B1 (en) | 2002-07-31 |
DE69527617T2 (de) | 2003-04-10 |
EP0755398A1 (en) | 1997-01-29 |
WO1995027713A1 (en) | 1995-10-19 |
US5811558A (en) | 1998-09-22 |
DE69527617D1 (de) | 2002-09-05 |
JPH09511516A (ja) | 1997-11-18 |
NO964346D0 (no) | 1996-10-11 |
ATE221533T1 (de) | 2002-08-15 |
AU2220695A (en) | 1995-10-30 |
NO964346L (no) | 1996-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2177644T3 (es) | Procedimiento para la resolucion de etodolac utilizando derivados de glucamina. | |
BR9506305A (pt) | Aparelho e processo para preparação de formas sólidas com desprendimento controlado do ingrediente ativo | |
MX9302214A (es) | Derivados de taxol y proceso para su preparacion | |
EA199800857A1 (ru) | Композиция для снятия боли и способ снятия боли | |
ES2173194T3 (es) | Procedimiento de racemizacion utilizado para la preparacion de levobupivacaina y sus analogos. | |
AR042345A2 (es) | Un procedimiento para la preparacion de una composicion farmaceutica para el tratamiento de aterosclerosis que contiene 8.9 - dehidroesterona o sus sales de la misma | |
PT99794A (pt) | Processo para a preparacao de novas piperazinas 1,4-dissubstituidas | |
GEP20033044B (en) | Method for Treating Atherosclerosis | |
PT93959A (pt) | Processo para a preparacao de derivados de sacarina uteis como inibidores proteoliticos de enzima | |
ES2187566T3 (es) | Formulaciones farmaceuticas mejoradas que contienen ibuprofeno y codeina. | |
HK1014927A1 (en) | Method of resolving racemic mixtures | |
ATE225171T1 (de) | Aminosäurederivate zur behandlung von schlaganfall | |
ES2126313T3 (es) | Hidrolisis enzimatica de los 4-metiltiobutironitrilos. | |
NO308661B1 (no) | FremgangsmÕte for fremstilling av 5-acetamido-2,3,4,5- tetradeoksy-4-guanidino-D-glycero-D-galakto-non-2-enopyranosonsyre og en forbindelse til bruk ved fremgangsmÕten | |
SE9501808D0 (sv) | New process | |
NO973366L (no) | Fremgangsmåte for behandling av multippel sklerose | |
DE69607113D1 (de) | Verfahren zur Racemisierung von optisch aktiven 1-Phenylethylamin-Derivaten | |
ES2163001T3 (es) | Nuevos derivados de borneol, procedimiento para su preparacion y su utilizacion farmaceutica. | |
NO990159D0 (no) | FremgangsmÕte for fremstilling av enantiomerisk anrikede N-acylazetidin-2-karboksylsyrer | |
NZ333443A (en) | Method of treating a plant disease comprising applying oxi-fulvic acid an acitve ingredient | |
ES2061712T3 (es) | Nuevos derivados sustituidos de 20,21-dinoreburnamenina, su procedimiento de preparacion y los nuevos productos intermedios asi obtenidos, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen. | |
ES2145292T3 (es) | Procedimiento bacteriano para la resolucion de cis-dioles racemicos. | |
PT854862E (pt) | Processo para a preparacao de um aminoacido activado | |
ES2056657T3 (es) | Derivado de la beta-fenilisoserina, su preparacion y su empleo. | |
AR023332A1 (es) | Compuestos derivados de benzamida sustituidos, proceso para su preparacion, formulaciones farmaceuticas que los comprenden, y metodo de tratamiento |